Please turn JavaScript on
header-image

Boston Biotech Clinical Research

Want to know the latest news and articles posted on Boston Biotech Clinical Research?

Then subscribe to their feed now! You can receive their updates by email, via mobile or on your personal news page on this website.

See what they recently published below.

Website title: Boston Biotech Clinical Research

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.24 / week

Message History

The BBCR consultants, experienced in orphan, rare and ultra-rare diseases, have advised biotech and venture capitalists for new indications evaluation and prioritization. BBCR’s team of industry experts can help match treatments to rare genetic conditions and unsolved diseases, then work with a product developer on the best plan to market. Candidate assessment for 505(b)(...

Read full story

With BBCR’s Strategic Clinical Innovation Organization (SCIO℠) method, we’re redefining how innovation meets efficiency in drug development—providing a clear, data-driven path to market approval. The SCIO℠ method works by learning and predicting—analyzing each pre-clinical asset to identify its true potential and forecasting the level of certainty for every strategic opti...

Read full story

The FDA recognizes biomarker development as a high priority area for future research. BBCR can help your company with your product development plan and validation. BBCR is dedicated to supporting pharmaceutical innovators in the specialized rare diseases and orphan drug indications by developing and nurturing the product’s unique strengths. It is our team’s operational mi...

Read full story

Partnering with BBCR Consulting means gaining the support of a specialized team committed to making the clinical trial process more efficient. We deliver expert guidance in Orphan Drug Development by designing tailored clinical and regulatory roadmaps with simplified programs and optimized protocols that align with each client’s needs. Our focus is on empowering phar...

Read full story
Read full story